ANTENATAL TREATMENT OF PERINATAL HEMOCHROMATOSIS WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN: THE FRENCH COHORT

被引：0
|
作者：
Baruteau, J. [1 ]
Heissat, S. [2 ]
Uzan, M. [3 ]
Cordier, M. [2 ]
Lamireau, T. [4 ]
Mitanchez, D. [5 ]
Dupuy, R. [6 ]
Broue, P. [7 ]
Debray, D. [8 ]
Guigonis, V. [9 ]
机构：
[1] Hop Robert Debre, Ctr Reference Malad Hereditaires Metabolisme, F-75019 Paris, France
[2] Groupement Hospitalier Est, Lyon, France
[3] Ctr Hospitalier Intercommunal Poissy, St Germain En Laye, France
[4] Hop Mere Enfant, Bordeaux, France
[5] Hop Armand Trousseau, Paris, France
[6] CH, St Brieuc, France
[7] Hop Enfants, Ctr Competence Malad Hereditaires Metabolisme Sud, Toulouse, France
[8] Hop Bicetre, Paris, France
[9] CHU Limogenes, Limoges, France
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E46 / E46
页数：1
相关论文
共 50 条
  • [1] Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin
    Whitington, Peter F.
    Kelly, Susan
    PEDIATRICS, 2008, 121 (06) : E1615 - E1621
  • [2] A case report of neonatal hemochromatosis treated by high-dose intravenous immunoglobulin
    Motomura, K.
    Sasaki, A.
    Hisano, M.
    Yamaguchi, K.
    Ito, Y.
    Ito, R.
    Kasahara, M.
    Matsumoto, K.
    Sago, H.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2014, 106 : 9 - 9
  • [3] The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings
    Okada, Noriki
    Sasaki, Aiko
    Saito, Jumpei
    Mitani, Yusuke
    Yachie, Akihiro
    Takahashi, Hironori
    Matsubara, Shigeki
    Tenkumo, Chiaki
    Tanaka, Hirokazu
    Hata, Toshiyuki
    Motomura, Kenichiro
    Nagasawa, Junko
    Wada, Yuka
    Sako, Mayumi
    Yamaguchi, Koshi
    Matsumoto, Kenji
    Nakamura, Hidefumi
    Sago, Haruhiko
    Mizuta, Koichi
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (01): : 142 - 148
  • [4] The renal risks of high-dose intravenous immunoglobulin treatment
    Stahl, M
    Schifferli, JA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (09) : 2182 - 2185
  • [5] PRETIBIAL MYXEDEMA AND HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN TREATMENT
    ANTONELLI, A
    NAVARRANNE, A
    PALLA, R
    ALBERTI, B
    SARACINO, A
    MESTRE, C
    ROGER, P
    AGOSTINI, S
    BASCHIERI, L
    THYROID, 1994, 4 (04) : 399 - 408
  • [6] Successful treatment of dermatomyositis with high-dose intravenous immunoglobulin
    Kuwano, Y
    Ihn, H
    Yazawa, N
    Kakinuma, T
    Asahina, A
    Kikuchi, K
    Tamaki, K
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (02) : 158 - 159
  • [7] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN GRAVES OPHTHALMOPATHY
    ANTONELLI, A
    SARACINO, A
    ALBERTI, B
    CANAPICCHI, R
    CARTEI, F
    LEPRI, A
    LADDAGA, M
    BASCHIERI, L
    ACTA ENDOCRINOLOGICA, 1992, 126 (01): : 13 - 23
  • [8] High-dose intravenous immunoglobulin treatment of multiple sclerosis
    Durelli, L
    Isoardo, G
    NEUROLOGICAL SCIENCES, 2002, 23 (Suppl 1) : S39 - S48
  • [9] High-dose intravenous immunoglobulin treatment of multiple sclerosis
    L. Durelli
    G. Isoardo
    Neurological Sciences, 2002, 23 : S39 - S48
  • [10] High-dose intravenous immunoglobulin treatment activates complement in vivo
    Mollnes, TE
    Hogåsen, K
    De Carolis, C
    Vaquero, E
    Nielsen, EW
    Fontana, L
    Perricone, R
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1998, 48 (03) : 312 - 317
12345